JP2015514797A - 代謝障害治療用組成物 - Google Patents

代謝障害治療用組成物 Download PDF

Info

Publication number
JP2015514797A
JP2015514797A JP2015507634A JP2015507634A JP2015514797A JP 2015514797 A JP2015514797 A JP 2015514797A JP 2015507634 A JP2015507634 A JP 2015507634A JP 2015507634 A JP2015507634 A JP 2015507634A JP 2015514797 A JP2015514797 A JP 2015514797A
Authority
JP
Japan
Prior art keywords
extract
composition
terminaria
elliptica
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015507634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514797A5 (enExample
Inventor
アルビンド・サクラニ
ニレシュ・マルピュア
パリクシット・ガイクワド
サティシュ・ナムデオ・サワント
トゥカラム・キサンラオ・マネ
ソメシュ・シャルマ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Enterprises Ltd
Original Assignee
Piramal Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Enterprises Ltd filed Critical Piramal Enterprises Ltd
Publication of JP2015514797A publication Critical patent/JP2015514797A/ja
Publication of JP2015514797A5 publication Critical patent/JP2015514797A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2015507634A 2012-04-23 2013-04-22 代謝障害治療用組成物 Pending JP2015514797A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636792P 2012-04-23 2012-04-23
US61/636,792 2012-04-23
PCT/IB2013/053155 WO2013160811A1 (en) 2012-04-23 2013-04-22 Composition for treating metabolic disorders

Publications (2)

Publication Number Publication Date
JP2015514797A true JP2015514797A (ja) 2015-05-21
JP2015514797A5 JP2015514797A5 (enExample) 2016-05-26

Family

ID=49482298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015507634A Pending JP2015514797A (ja) 2012-04-23 2013-04-22 代謝障害治療用組成物

Country Status (16)

Country Link
US (1) US20150290265A1 (enExample)
EP (1) EP2841080A4 (enExample)
JP (1) JP2015514797A (enExample)
KR (1) KR20150003862A (enExample)
CN (1) CN104244962A (enExample)
AU (1) AU2013254329A1 (enExample)
BR (1) BR112014026326A2 (enExample)
CA (1) CA2870907A1 (enExample)
IL (1) IL235317A0 (enExample)
IN (1) IN2014MN02269A (enExample)
MX (1) MX2014012742A (enExample)
NZ (1) NZ701133A (enExample)
RU (1) RU2014145931A (enExample)
SA (1) SA113340494B1 (enExample)
TW (1) TW201343174A (enExample)
WO (1) WO2013160811A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3233188A4 (en) * 2014-12-19 2018-11-07 Halo Life Science, LLC Use of ellagic acid dihydrate in pharmaceutical formulations to regulate blood glucose levels
EP3529245A4 (en) 2016-10-24 2020-12-23 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THE LATEST
MA47212A (fr) 2017-01-06 2019-11-13 Yumanity Therapeutics Inc Méthodes de traitement de troubles neurologiques
WO2019084157A1 (en) 2017-10-24 2019-05-02 Yumanity Therapeutics, Inc. COMPOUNDS AND USES THEREOF
MX2020007394A (es) 2018-01-10 2020-09-03 Brightseed Inc Metodo para modular el metabolismo.
ES3043183T3 (en) 2018-03-23 2025-11-25 Janssen Pharmaceutica Nv Compounds and uses thereof
MA54829A (fr) 2019-01-24 2021-12-01 Yumanity Therapeutics Inc Composés et leurs utilisations
KR20220100896A (ko) 2019-11-11 2022-07-18 브라이트씨드, 인크. 추출물, 소모가능 생성물 및 추출물에서 생물활성 대사산물을 농후화하는 방법
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение
KR102408566B1 (ko) * 2020-04-09 2022-06-16 대한민국 터미날리아 비아라타 추출물을 이용한 피부 주름 개선용 조성물
JP2023144436A (ja) * 2022-03-28 2023-10-11 住友化学株式会社 エラグ酸含有組成物の製造方法及びエラグ酸含有組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤
JP2008537539A (ja) * 2005-02-23 2008-09-18 アヴェスタジェン リミテッド 植物抽出物およびそのための方法と使用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005053864A (ja) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk 糖尿病疾患予防・治療剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006188486A (ja) * 2004-12-07 2006-07-20 Toyo Shinyaku:Kk 体脂肪蓄積抑制または低減剤
JP2008537539A (ja) * 2005-02-23 2008-09-18 アヴェスタジェン リミテッド 植物抽出物およびそのための方法と使用

Also Published As

Publication number Publication date
IN2014MN02269A (enExample) 2015-07-24
MX2014012742A (es) 2015-04-08
US20150290265A1 (en) 2015-10-15
RU2014145931A (ru) 2016-06-20
SA113340494B1 (ar) 2015-12-24
EP2841080A4 (en) 2015-11-25
BR112014026326A2 (pt) 2017-06-27
NZ701133A (en) 2016-08-26
TW201343174A (zh) 2013-11-01
AU2013254329A1 (en) 2014-11-13
IL235317A0 (en) 2014-12-31
CA2870907A1 (en) 2013-10-31
EP2841080A1 (en) 2015-03-04
WO2013160811A1 (en) 2013-10-31
KR20150003862A (ko) 2015-01-09
CN104244962A (zh) 2014-12-24

Similar Documents

Publication Publication Date Title
US20150290265A1 (en) Composition for treating metabolic disorders
CN111789918B (zh) 一种抗冠状病毒的中药组合物及其制备方法和用途
TWI454261B (zh) 作為治療劑之色酮類
KR100545723B1 (ko) 솔라눔속 식물의 수용성 추출물, 그 제조방법, 및 그수용성 추출물을 함유하는 약제학적 조성물
RU2668135C1 (ru) Фармацевтическая композиция для лечения и предотвращения дегенеративных неврологических нарушений, которая содержит, в качестве активного ингредиента, смешанный экстракт коры корня пиона полукустарникового, корня дудника даурского и корня володушки или его фракцию
Thabet et al. Validation of the antihyperglycaemic and hepatoprotective activity of the flavonoid rich fraction of Brachychiton rupestris using in vivo experimental models and molecular modelling
CN104474029A (zh) 欧洲白蜡树种子提取物及其治疗应用
Aggrey et al. Indole alkaloid from Nauclea latifolia promotes LDL uptake in HepG2 cells by inhibiting PCSK9
US20100297760A1 (en) Pharmaceutical composition and a method for treatment of prostate cancer
JP2015509976A (ja) 代謝障害の治療用薬草組成物
Khalil et al. Nano-encapsulated form of citrus medica for osteoporosis treatment in animal model
JP6758799B2 (ja) 医薬組成物
CN111558007B (zh) 一种玉米根提取物及其制备方法和应用
US20220249428A1 (en) Discovery of potent [alpha]-glucosidase inhibitors from heterophragma adenophyllum
CN101287481A (zh) 用于治疗肝细胞癌的药物组合物
Mangathayaru et al. Estrogenic effect of Erythrina variegata L. in prepubertal female rats
CN102716275A (zh) 一种具有抗焦虑作用的药物组合物的检测方法
KR20080112090A (ko) 육두구 가종피 추출 화합물을 유효성분으로 포함하는당뇨병 또는 피피에이알-감마 매개 질환 예방 및 치료용약학적 조성물
Ismeel Cytogenetic and cytotoxic studies on the effect of phytoinvestigated active compounds of Hyoscyamus niger (in vivo and ex vivo)
Ogar et al. Effect of Ethanol and N-Hexane Combined Extracts of Selected Plants on Liver Enzymes in Wistar Rats: http://www. doi. org/10.26538/tjpps/v2i4. 4
Ugwu et al. Preliminary Standardization of Fadogia cienkowskii Schweinf (Rubiaceae) Leaves and Evaluation of the Anti-inflammatory Activity of the Methanol Extract.
US20080227854A1 (en) Compound 3-(1, 1-Dimethyl-Allyl)-6-Hydroxy-Chromen-2-One and its Pharmaceutically Acceptable Salts Thereof
PT1508334E (pt) Extracto solúvel em água a partir de planta do género solanum e o seu processo de preparação, e composição farmacêutica contendo o extracto solúvel em água
Dahiya et al. Evaluation of hypoglycemic and antidiabetic activity of amaranthus hybridus linn. Root extracts
CN111053766A (zh) 牡丹种子提取物及从中分离的茋类化合物在神经保护方面的用途

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160330

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170822